Drugs / BLYG8824A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04468607 | Aug 2020 → Oct 2024 | colorectal cancer | Genentech, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BLYG8824A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04468607 ↗ |
| Route | Intravenous | “Administered Intravenously” NCT04468607 ↗ |